A very warm welcome to all of you us drug for modern us says its applying for emergency approval of its covert 1000 vaccine in both europe and the united states. Well that could lead to distribution in the u. S. As soon as december, the company says full trial results show its vaccine was 94 percent effective with no serious side effects while the filing this stuff mcgurn is product to be the 2nd vaccine likely to receive special authorization after the one developed by by sir and beyond tech. Well joining me now is yanis announces he is with the european a Public Health alliance and is a board member of European Medicines Agency is known as e m a, which is dealing with murder and as a request for authorization. A very good evening, sir. Why do you think were there now will be granted approval by the way. Good evening. It is hard to tell and obviously i dont speak on behalf of the agency, but i will. My message would be that we need to let the regulators do their job. We need to let the regulators look at these, they that we need to make sure that we get these very promising, good news from the Companies Press releases. Weve seen quite a few of them over the past few weeks, but now we need to make sure that there we need to crosscheck this data and we need to make sure that the regulators have the time and the tools on their disposal to assess the companys claims how many doses will become available, you think of how quickly can they be rolled out . Well, we will see more there now has said that europe will have to wait. We understand the scale up of the manufacturing capacity and obviously the distribution ease of big challenge for all. d companies and the public european countries, governments are teaming up with pharma companies, as we speak to help them by also essentially by seeing them financially to scale up and to boost Production Capacity to make sure that these products, when authorized by be made are allocated in this review to, to citizens in europe and beyond. And look at the vaccination start. Well, im not, im not a fortune teller and i met you because we dont have the, we do not have the green light yet. From the regulator. Im pretty confident of the regulator and we do its job and we will have a safe and effective products. But once these products are in the market, we will have to keep a close eye on them